Anjali Yadava

Summary

Affiliation: Walter Reed Army Medical Center
Country: USA

Publications

  1. ncbi Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems
    Anjali Yadava
    Department of Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA
    Infect Immun 71:4961-9. 2003
  2. ncbi Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion
    Joanne M Lumsden
    Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, MD 20910, USA
    Infect Immun 79:3492-500. 2011
  3. ncbi Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria
    Anjali Yadava
    Malaria Vaccine Branch, United States Military Malaria Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA
    J Infect Dis 205:1456-63. 2012
  4. ncbi A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites
    Anjali Yadava
    Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA
    Infect Immun 75:1177-85. 2007
  5. ncbi Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice
    Joanne M Lumsden
    Malaria Vaccine Branch United States, Military Malaria Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, United States
    Vaccine 30:3311-9. 2012
  6. ncbi Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax
    Brian A Bell
    Pilot BioProduction Facility, Walter Reed Army Institute of Research, Silver Spring, MD 20910, United States
    Vaccine 27:1448-53. 2009
  7. ncbi Positive rK39 serologic assay results in US servicemen with cutaneous leishmaniasis
    Joshua D Hartzell
    Infectious Diseases Division, Walter Reed Army Medical Center, Washington, District of Columbia 20307, USA
    Am J Trop Med Hyg 79:843-6. 2008
  8. ncbi Genome-wide expression profiling in malaria infection reveals transcriptional changes associated with lethal and nonlethal outcomes
    Kurt Schaecher
    Department of Immunology, Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, MD 20910, USA
    Infect Immun 73:6091-100. 2005

Collaborators

Detail Information

Publications8

  1. ncbi Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems
    Anjali Yadava
    Department of Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA
    Infect Immun 71:4961-9. 2003
    ..These antibodies recognize EBA-175 present on merozoites as well as in sporozoites by immunofluorescence. Our results suggest that the Pichia-based EBA-F2 vaccine construct has further potential to be developed for clinical use...
  2. ncbi Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion
    Joanne M Lumsden
    Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, MD 20910, USA
    Infect Immun 79:3492-500. 2011
    ..We conclude that the combination of VMP001 and GLA-SE is safe and immunogenic in monkeys and may serve as a potential second-generation vaccine candidate against P. vivax malaria...
  3. ncbi Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria
    Anjali Yadava
    Malaria Vaccine Branch, United States Military Malaria Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA
    J Infect Dis 205:1456-63. 2012
    ..In addition, we report that vaccination of mice with VMP001, a P. vivax CSP vaccine candidate, reduces, not enhances, P. berghei infection in mice...
  4. ncbi A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites
    Anjali Yadava
    Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA
    Infect Immun 75:1177-85. 2007
    ..These results strongly suggest that recombinant CS is biologically active and highly immunogenic across major histocompatibility complex strains and raises the prospect that in humans this vaccine may induce protective immune responses...
  5. ncbi Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice
    Joanne M Lumsden
    Malaria Vaccine Branch United States, Military Malaria Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, United States
    Vaccine 30:3311-9. 2012
    ..Based on these results, we conclude that the combination of VMP001 and GLA-SE is highly immunogenic in mice and may serve as a potential second-generation vaccine candidate against vivax malaria...
  6. ncbi Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax
    Brian A Bell
    Pilot BioProduction Facility, Walter Reed Army Institute of Research, Silver Spring, MD 20910, United States
    Vaccine 27:1448-53. 2009
    ....
  7. ncbi Positive rK39 serologic assay results in US servicemen with cutaneous leishmaniasis
    Joshua D Hartzell
    Infectious Diseases Division, Walter Reed Army Medical Center, Washington, District of Columbia 20307, USA
    Am J Trop Med Hyg 79:843-6. 2008
    ..2% and 28.8% had positive results, respectively. CL is associated with a reactive rK39 assay result in some patients without clinical evidence of VL...
  8. ncbi Genome-wide expression profiling in malaria infection reveals transcriptional changes associated with lethal and nonlethal outcomes
    Kurt Schaecher
    Department of Immunology, Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, MD 20910, USA
    Infect Immun 73:6091-100. 2005
    ....